Relative Effectiveness of the Cell-Cultured Quadrivalent Influenza Vaccine Compared to Standard, Egg-derived Quadrivalent Influenza Vaccines in Preventing Influenza-like Illness in...

por Boikos, Constantina, Sylvester, Gregg C, Sampalis, John S, Mansi, James A
Publicado 2020

LB-2. Relative Effectiveness of aIIV3 versus IIV4 and HD-IIV3 In Preventing Influenza-Related Medical Encounters in Adults ≥65 Years of Age at High Risk for Influenza Complications...

por Fischer, Lauren, O'Brien, Dan, Vasey, Joseph, Sylvester, Gregg C, Mansi, James A
Publicado 2020

Effectiveness of the Cell-Derived Inactivated Quadrivalent Influenza Vaccine in Individuals at High Risk of Influenza Complications in the 2018–2019 United States Influenza Season...

por Boikos, Constantina, Imran, Mahrukh, Nguyen, Van Hung, Ducruet, Thierry, Sylvester, Gregg C, Mansi, James A
Publicado 2021

Relative Effectiveness of the Cell-derived Inactivated Quadrivalent Influenza Vaccine Versus Egg-derived Inactivated Quadrivalent Influenza Vaccines in Preventing Influenza-related...

por Boikos, Constantina, Fischer, Lauren, O’Brien, Dan, Vasey, Joe, Sylvester, Gregg C, Mansi, James A
Publicado 2021

Effectiveness of the Adjuvanted Influenza Vaccine in Older Adults at High Risk of Influenza Complications

por Boikos, Constantina, Imran, Mahrukh, Nguyen, Van Hung, Ducruet, Thierry, Sylvester, Gregg C., Mansi, James A.
Publicado 2021

Relative Effectiveness of Adjuvanted Trivalent Inactivated Influenza Vaccine Versus Egg-derived Quadrivalent Inactivated Influenza Vaccines and High-dose Trivalent Influenza Vaccin...

por Boikos, Constantina, Fischer, Lauren, O’Brien, Dan, Vasey, Joe, Sylvester, Gregg C, Mansi, James A
Publicado 2021

A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the r...

por McLaughlin, John M, Utt, Eric A, Hill, Nina M, Welch, Verna L, Power, Edward, Sylvester, Gregg C
Publicado 2015

Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023

por McLean, Huong Q., Petrie, Joshua G., Hanson, Kayla E., Meece, Jennifer K., Rolfes, Melissa A., Sylvester, Gregg C., Neumann, Gabriele, Kawaoka, Yoshihiro, Belongia, Edward A.
Publicado 2023